Stocks
Editas Medicine (EDIT) EBITDA US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA, bln rub | ? | -138.1 | -130.9 | -188.1 | -219.6 | -163.1 | -219.1 | ||
| Changes by years, y/y, % | +22% | -5% | +44% | +17% | -26% | +7.5% | |||
Editas Medicine. EBITDA US GAAP, bln rub
Editas Medicine. EBITDA US GAAP, changes, %
Editas Medicine. EBITDA US GAAP, sum by quarters, bln rub
Editas Medicine (EDIT) EBITDA US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| EBITDA, bln rub | ? | -48.6 | -22.5 | -65.6 | -70.5 | -60.5 | -219.1 | |
| Changes by years, y/y, % | -13% | -65% | +29% | +60% | +24% | |||
| Changes by quarters, q/q, % | +10% | -54% | +192% | +7% | -14% | |||
